Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
TRACON Pharmaceuticals (TCON) just unveiled an update.
David Lazar stepped down as Chief Business Development Officer of his company on June 19, 2024, on his own accord. His departure was not due to any conflicts with the company’s operations or management.
See more data about TCON stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue